Close Menu

NEW YORK (GenomeWeb) – Premaitha Health and Coastal Genomics have signed an agreement to develop technologies for clinical DNA sequencing tests, Premaitha said today.

Under the agreement, Coastal Genomics, based in Vancouver, and Premaitha, located in Manchester, UK, plan to develop technologies "to enhance aspects of Premaitha Health's in vitro diagnostic product portfolio" for reproductive health and other applications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.